|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Current assets | ||||||||||||
| Cash | ||||||||||||
| Other assets - current | ||||||||||||
| Prepaid expenses - Current | ||||||||||||
| Franchise tax receivable | ||||||||||||
| Income tax receivable | ||||||||||||
| Total Current Assets | ||||||||||||
| Other assets - non-current | ||||||||||||
| Prepaid expenses - Noncurrent | ||||||||||||
| Investments held in Trust Account | ||||||||||||
| TOTAL ASSETS | ||||||||||||
| LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS' DEFICIT | ||||||||||||
| Current liabilities | ||||||||||||
| Accounts payable and accrued expenses | ||||||||||||
| Franchise tax payable | ||||||||||||
| Deferred offering costs | ||||||||||||
| Income tax payable | ||||||||||||
| Excise tax payable | ||||||||||||
| Class A Common Stock | ||||||||||||
| Total excise tax payable | ||||||||||||
| Promissory Note - Related Party | ||||||||||||
| Stockholders redemption payable | ||||||||||||
| Due to Sponsor | ||||||||||||
| Total Liabilities | ||||||||||||
| Class A common stock subject to possible redemption; $0.0001 par value; 1,574,369 and 2,744,649 shares at redemption values $11.46 and $10.76 at December 31, 2024, and December 31, 2023, respectively | ||||||||||||
| Stockholders' Deficit | ||||||||||||
| Common Stock | ||||||||||||
| Class A Common Stock | ||||||||||||
| Class B Common Stock | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated Deficit | ||||||||||||
| Total Stockholders' Deficit | ||||||||||||
| TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS' DEFICIT |
Loading...
